Tulobuterol (HCl)
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Tulobuterol (HCl) is a bronchodilator, similar to salbutamol. Tulobuterol (HCl) is used prophylactically in reversible obstructive air way disease.
Indications
Tulobuterol (HCl) is primarily indicated in conditions like Asthma, Bronchospasm, Chronic bronchitis, Emphysema, COPD.
Contraindications
Tulobuterol (HCl)
Side Effects
The severe or irreversible adverse effects of Tulobuterol (HCl), which give rise to further complications include Hypertension, Angina, CNS stimulation. The symptomatic adverse reactions produced by Tulobuterol (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Vomiting, Palpitation, Insomnia, Vertigo, Tachycardia, Tremors, Diaphoresis, Heartburn, Nervousness, Agitation, Anxiety, Sweating, Cramps.
Warnings
Use with caution in the patient with diabetes mellitus, hypertension and hyperthyroidism. As with other sympathomimetic bronchodilators agents, tulobuterol should be administered cautiously to cardiac patient, especially those with associated arrhythmias or coronary insufficiency. The concomitant systemic use of tulobuterol with other combined effect on the cardiovascular system may be deleterious to the patient. Tulobuterol should not be prescribed together with beta-blocking agents. Although an intravenous injection of a cardio-selective beta-blocking agent can be given as an specific antidote for tulobuterol over dosage, the agents should be used with caution in the patients with bronchospasm.
High Risk Groups
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
1 mg (1 (1)) 12 hourly PO —
Child Dosage
0.02 to 0.04 mg/kg (0.03 (0.03)) 12 hourly Oral — Recommended for 6-12 Yrs of Children
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Tulobuterol (HCl) was found.
Storage
No storage information is recorded for this medicine yet.
Available Brands in Pakistan
1 active brand listed alphabetically.
BREMAX
ActiveABBOTT LABORATORIES (PAKISTAN) LIMITED.
DML: BREMAX
SyrupTabs